CrossRef Naringin mitigates liver damage in a tissue-engineered liver of metabolic dysfunction-associated steatotic liver disease model by promoting autophagy via the mTOR-ULK1 pathway Jihui Jia, Yizhi Zhang, Jing Lin, Zhongping Duan, Yu Chen, Xiaohui Zhang Molecular Biology Reports .2025;[Epub] CrossRef Dietary supplementation with a designer metabolic modulator improves MASLD and associated anxiety in mice Agnese Segala, Gaia Favero, Emanuela Bottani, Alice Vetturi, Emirena Garrafa, Edoardo Parrella, Chiara Ruocco, Maurizio Ragni, Rita Rezzani, Enzo Nisoli, Alessandra Valerio Frontiers in Pharmacology .2025;[Epub] CrossRef From Steatosis to Immunosenescence: The Impact of Metabolic Dysfunction on Immune Aging in HIV and Non-HIV Populations Carlo Acierno, Maria Frontuto, Giulio Francesco De Stefano, Ana Erezanu, Andrea Limone, Simona Morella, Francesco Picaro, Donatella Palazzo, Michele Gilio Biomedicines .2025
All patients should see a doctor for guidance on proper use
Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy
org/10.1093/ajcn/67.2.332
Is Ozempic approved for medical weight loss
In the most recent Phase 3 trial, participants on the 12 mg dose lost an average of 28.7% of their body weight at 68 weeks